Skip to main content

Financial news

The newsroom

Headlines from the Federal Reserve, ECB, Bank of Japan, Bank of England, SEC EDGAR, the White House and the DOJ. Context notes are neutral and information-only, Kresmion publishes no buy or sell recommendations.

Public RSS feeds · refreshed every 30 minutes

SourceAllSEC EDGARDOJBank of JapanWhite HouseECBFederal ReserveBank of England
TopicAllenforcementfilingsmonetarypolicy

5793 items from SEC EDGAR · clear filters

  • SEC EDGARfilings
    8-K - SURF AIR MOBILITY INC. (0001936224) (Filer)

    Surf Air Mobility Inc. filed an 8-K reporting entry into a material definitive agreement, the creation of a direct financial obligation or off-balance sheet arrangement, and the inclusion of financial statements and related exhibits.

  • SEC EDGARfilings
    8-K - Stabilis Solutions, Inc. (0001043186) (Filer)

    Stabilis Solutions, Inc. filed a Form 8-K indicating that specific matters have been submitted to a vote of its security holders.

  • SEC EDGARfilings
    8-K - SolarMax Technology, Inc. (0001519472) (Filer)

    SolarMax Technology, Inc. filed a Form 8-K reporting material modifications to security holders' rights, amendments to its articles of incorporation and bylaws including a fiscal year change, and accompanying financial statements and exhibits.

  • SEC EDGARfilings
    8-K - Wheeler Real Estate Investment Trust, Inc. (0001527541) (Filer)

    Wheeler Real Estate Investment Trust, Inc. filed a Form 8-K on August 11 2026 reporting unregistered sales of equity securities, as disclosed in Item 3.02 of the filing (Accession No. 0001527541-26-000272).

  • SEC EDGARfilings
    8-K - AIM ImmunoTech Inc. (0000946644) (Filer)

    AIM ImmunoTech Inc. filed a Form 8-K with the SEC on August 11, 2026, including a Regulation FD disclosure (Item 7.01) and financial statements and exhibits (Item 9.01).

  • SEC EDGARfilings
    8-K - Syra Health Corp (0001922335) (Filer)

    Syra Health Corp filed a Form 8-K on August 11, 2026, reporting its results of operations and financial condition and providing its financial statements and related exhibits.

  • SEC EDGARfilings
    8-K - Apollo Global Management, Inc. (0001858681) (Filer)

    Apollo Global Management filed a Form 8-K with the SEC on August 11, 2026, providing a Regulation FD disclosure under Item 7.01.

  • SEC EDGARfilings
    8-K - Athene Holding Ltd. (0001527469) (Filer)

    Athene Holding Ltd. filed a Form 8-K with the SEC on August 11 2026, containing an Item 7.01 Regulation FD Disclosure.

  • SEC EDGARfilings
    8-K - ESS Tech, Inc. (0001819438) (Filer)

    ESS Tech, Inc. filed a Form 8-K on August 6, 2026, reporting its results of operations and financial condition and disclosing other events.

  • SEC EDGARfilings
    8-K - Loar Holdings Inc. (0002000178) (Filer)

    Loar Holdings Inc. filed a Form 8-K on August 6, 2026, reporting its results of operations and financial condition and including its financial statements and related exhibits.

  • SEC EDGARfilings
    8-K - MDU RESOURCES GROUP INC (0000067716) (Filer)

    MDU Resources Group Inc filed a Form 8-K on August 6, 2026, containing Item 2.02 results of operations and financial condition, Item 7.01 Regulation FD disclosure, and Item 9.01 financial statements and exhibits.

  • SEC EDGARfilings
    8-K - UGI CORP /PA/ (0000884614) (Filer)

    UGI Corp filed a Form 8-K on August 6, 2026, containing Item 2.02 results of operations and financial condition, Item 7.01 Regulation FD disclosure, and Item 9.01 financial statements and exhibits.

  • SEC EDGARfilings
    8-K - AQUABOUNTY TECHNOLOGIES INC (0001603978) (Filer)

    Aquabounty Technologies Inc. filed a Form 8-K on August 6, 2026, containing a Regulation FD disclosure and accompanying financial statements and exhibits.

  • SEC EDGARfilings
    8-K - ACORN ENERGY, INC. (0000880984) (Filer)

    Acorn Energy, Inc. filed a Form 8-K on August 6, 2026, reporting results of operations and financial condition (Item 2.02) and providing financial statements and exhibits (Item 9.01).

  • SEC EDGARfilings
    8-K - MARKETWISE, INC. (0001805651) (Filer)

    Marketwise, Inc. filed a Form 8-K on August 6, 2026, reporting its results of operations and financial condition and providing financial statements and related exhibits.

  • SEC EDGARfilings
    8-K - INVESTORS TITLE CO (0000720858) (Filer)

    Investors Title Co filed a Form 8-K on August 6, 2026, disclosing its results of operations and financial condition and providing its financial statements and related exhibits.

  • SEC EDGARfilings
    8-K - Praxis Precision Medicines, Inc. (0001689548) (Filer)

    Praxis Precision Medicines, Inc. filed a Form 8-K on August 6, 2026, reporting its results of operations and financial condition, providing a Regulation FD disclosure, and attaching related financial statements and exhibits.

  • SEC EDGARfilings
    8-K - Stran & Company, Inc. (0001872525) (Filer)

    Stran & Company, Inc. filed a Form 8-K on August 6, 2026, containing a Regulation FD disclosure (Item 7.01) and its financial statements and related exhibits (Item 9.01).

  • SEC EDGARfilings
    8-K - CION Investment Corp (0001534254) (Filer)

    CION Investment Corp filed a Form 8-K on August 6, 2026 (Accession No. 0001104659-26-091692), reporting its results of operations and financial condition, providing a Regulation FD disclosure, and including its financial statements and exhibits.

  • SEC EDGARfilings
    8-K - Ocugen, Inc. (0001372299) (Filer)

    Ocugen, Inc. filed a Form 8-K on August 6, 2026, reporting its results of operations and financial condition and providing its financial statements and related exhibits.

  • SEC EDGARfilings
    8-K - Agassi Sports Entertainment Corp. (0000930245) (Filer)

    Agassi Sports Entertainment Corp. filed a Form 8-K with the SEC on August 6, 2026, containing a Regulation FD disclosure and the company’s financial statements and related exhibits.

  • SEC EDGARfilings
    8-K - OLENOX INDUSTRIES INC. (0001023994) (Filer)

    Olenox Industries Inc. filed a Form 8-K reporting a notice of delisting or failure to meet a continued listing rule and a transfer of its listing, accompanied by Regulation FD disclosure and accompanying financial statements and exhibits.

  • SEC EDGARfilings
    8-K - AEMETIS, INC (0000738214) (Filer)

    Aemetis, Inc. filed a Form 8-K on August 6, 2026, reporting its results of operations and financial condition, providing a Regulation FD disclosure, and attaching financial statements and related exhibits.

  • SEC EDGARfilings
    8-K - CG Oncology, Inc. (0001991792) (Filer)

    CG Oncology, Inc. submitted a Form 8-K on August 6, 2026 (Accession No. 0001193125-26-336886), containing Item 2.02 results of operations and financial condition, Item 8.01 other events, and Item 9.01 financial statements and exhibits.

  • SEC EDGARfilings
    8-K - Arteris, Inc. (0001667011) (Filer)

    Arteris, Inc. filed a Form 8-K on August 6, 2026, reporting departures and appointments of directors and officers, related compensatory arrangements, a Regulation FD disclosure, and accompanying financial statements and exhibits.

  • SEC EDGARfilings
    8-K - Vystar Corp (0001308027) (Filer)

    Vystar Corp filed an 8-K reporting entry into a material definitive agreement, completion of an acquisition or asset disposition, unregistered sales of equity securities, and accompanying financial statements and exhibits.

  • SEC EDGARfilings
    8-K - MAXIMUS, INC. (0001032220) (Filer)

    Maximus Inc. filed a Form 8-K on August 6, 2026, reporting its results of operations and financial condition and including financial statements and related exhibits. The filing, accession number 0001032220-26-000033, is 661 KB.

  • SEC EDGARfilings
    8-K - ONCOR ELECTRIC DELIVERY CO LLC (0001193311) (Filer)

    Oncor Electric Delivery Co LLC filed a Form 8-K on August 6, 2026, reporting results of operations and financial condition, providing a Regulation FD disclosure, and attaching financial statements and related exhibits.

  • SEC EDGARfilings
    8-K - Ensysce Biosciences, Inc. (0001716947) (Filer)

    Ensysce Biosciences filed an 8-K reporting entry into a material definitive agreement, completion of an asset acquisition/disposition, unregistered equity sales, modifications to security holder rights, changes in directors/officers and compensation, and amendments to its charter and fiscal year.

  • SEC EDGARfilings
    8-K - Annexon, Inc. (0001528115) (Filer)

    Annexon, Inc. filed a Form 8-K on August 6, 2026, reporting other events under Item 8.01 and providing its financial statements and related exhibits under Item 9.01.